Amidst the Banking Panic, JPMorgan Stands Strong. An Opportunity?
In case you missed it, something big happened in the banking world last week. Silicon Valley Bank (SIVB), a favorite bank of tech startups, went bust after a massive run on deposits and a failed attempt to raise capital. This was the worst bank failure since the 2008 crisis. You may be wondering what this…
Stocks on the Brink: The Market’s High-Stakes Waiting Game
When you follow the stock market, it is easy to get swept away by the daily drama of 24/7 financial news. Every piece of news, every data point, and every market move is dissected and debated and takes on often unwarranted significance as a result. I do understand the irony of me pointing that out,…
Turn the Fed’s Faster Interest Rate Increases Into Money With This Simple Trick
Are you feeling the pinch of inflation? I know I am. Everything I buy seems to cost more than it used to, from food to gas to even Netflix! And it doesn’t look like things are going to get easier anytime soon, according to the Federal Reserve. The Fed’s boss, Jerome Powell, said on Tuesday…
This is What This Indicator With a 60-Year History of Calling Bull Markets Sees Stocks Now
What is the stock market going to do next? Will there be a new bull market? That is the question that every investor wishes they could answer accurately. Regrettably, there is no way to predict how stocks will perform. Is there one? Many investors like to look at indicators that have proven to be trustworthy…
Why Intellia Therapeutics Stock Is a “Strong Buy”
Apart from artificial intelligence (AI) and cryptocurrency, genome editing research and development has long been a popular stock on Wall Street. Intellia Therapeutics (NASDAQ:NTLA) just earned a critical regulatory green light in this field, propelling Intellia Therapeutics stock higher. Analysts rate the biotechnology firm as a “Strong Buy,” but it still demands extensive due diligence…
This Stock Is Extremely Oversold, But a TikTok Ban Could Be a Game Changer!
As the US government moves closer to banning TikTok, a popular video-sharing app that is owned by a Chinese company, many investors are focusing attention on this massively oversold social media stock. TikTok is available in over 150 countries, has over 1 billion users, and has been downloaded over 210 million times in the United…
Another Case of So Bad, They’re Good: Kohl’s Earnings
Kohl’s Corporation (NYSE:KSS) reported a dismal Q4 2022 earnings report, missing top and bottom lines and decreasing its full-year 2023 expectations. Kohl’s missed practically every metric, with shares initially falling in the post-market but rebounding the next day, perplexing investors. Because the market is always looking ahead, stocks tend to fall even if a business…
LVMH Making a Killing, as Demand for Luxury Goods Shooting Up Again
In western Washington, I grew up on a 24-acre vegetable farm. It took a lot of effort on my part and my family’s part. But, because farming is a low-paying job, that hard work never converted into material wealth. Our family rarely had the money for niceties, especially LVMH goods, no matter how hard my…
Is Now the Time to Buy CVS Health?
CVS Health (NYSE: CVS) shares peaked over a year ago, but have since plummeted almost 27% from their all-time high. Dividend growth investors are already sniffing around for bargains in this one-of-a-kind healthcare business. Is CVS Health a good addition to your dividend growth portfolio? To find out, let’s take a look at some of…
John’s favorite AI stock
For those of you that have been following us over the last 6-8 months, you know that we have been calling the AI trend for at least that long. In fact, I think we have been ahead of the curve in saying that AI is really going to be HUGE for investors of AI stock….
